Cargando…

Coronary stenting versus bypass surgery in elderly with multivessel disease: long-term mortality rate is still up for debate

Detalles Bibliográficos
Autores principales:	Braber, T. L., Hermanides, R. S., Ottervanger, J. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683643/ https://www.ncbi.nlm.nih.gov/pubmed/33170440 http://dx.doi.org/10.1007/s12471-020-01514-x

Ejemplares similares

Reply to the letter of Braber et al.: ‘Coronary stenting versus bypass surgery in elderly with multivessel disease: long-term mortality rate is still up for debate’
por: Gimbel, M. E., et al.
Publicado: (2020)

Long-term follow-up after bypass surgery or coronary stenting in elderly with multivessel disease
por: Gimbel, M. E., et al.
Publicado: (2020)

Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease
por: Naito, Ryo, et al.
Publicado: (2015)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020)

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
por: Papadopoulos, Kyriacos, et al.
Publicado: (2017)

Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease
por: Maurício de Abreu Filho, Luciano, et al.
Publicado: (2011)

Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis
por: Zhu, Peng, et al.
Publicado: (2015)

Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era?
por: Ono, M., et al.
Publicado: (2020)

Comparing mortality and myocardial infarction between coronary artery bypass grafting and drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis
por: Qi, Xiaolong, et al.
Publicado: (2014)

Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
por: Xin, Xiaojun, et al.
Publicado: (2019)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting in Patients With Multivessel Coronary Artery Disease
por: Li, Dongjie, et al.
Publicado: (2021)

Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: a meta-analysis
por: Yu, Li, et al.
Publicado: (2022)

Coronary artery bypass grafting versus stents
por: Iglézias, JCR, et al.
Publicado: (2013)

Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents
por: Su, Chieh-Shou, et al.
Publicado: (2019)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Diabetics with Multivessel Coronary Artery Disease: The Korean Multicenter Revascularization Registry (KORR)
por: Gwon, Hyeon-Cheol, et al.
Publicado: (2005)

Nonsternotomy multivessel coronary artery bypass grafting: A key development in cardiac surgery
por: Ruel, Marc
Publicado: (2021)

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes
por: Panchal, Kanaiya, et al.
Publicado: (2012)

Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
por: Bhatt, Deepak L, et al.
Publicado: (2001)

Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype: An analysis of 6,682 patients with multivessel disease
por: Raja, Shahzad G., et al.
Publicado: (2018)

Influenza vaccination in the elderly: why are the overall benefits still hotly debated?
por: TRUCCHI, C., et al.
Publicado: (2015)

Unexpected Evolution After Multivessel Coronary Artery Bypass Grafting in a Patient With Kawasaki Disease
por: Victor, Samjeris, et al.
Publicado: (2021)

The Feasibility and Early Results of Multivessel Minimally Invasive Coronary Artery Bypass Grafting for All Comers
por: Demirsoy, Ergun, et al.
Publicado: (2023)

Staged versus “one-time” multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome
por: Yu, Xiao-Fan, et al.
Publicado: (2016)

Debate of Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in a Multimorbidity Patient with Complex Coronary Lesions
por: Mitsiadis, Sotirios, et al.
Publicado: (2020)

Up-to-Date Clinical Practice in Percutaneous Coronary Intervention for Multivessel Disease
por: Hong, Sung-Jin
Publicado: (2023)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
por: Her, Ae-Young, et al.
Publicado: (2023)

Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data
por: Hakeem, Abdul, et al.
Publicado: (2013)

Mid-term follow-up outcomes of 2-staged hybrid coronary revascularization compared with off-pump coronary artery bypass for patients with multivessel coronary artery disease
por: Wu, Song, et al.
Publicado: (2017)

Is coronary multivessel disease in acute myocardial infarction patients still associated with worse clinical outcomes at 1‐year?
por: Puymirat, Etienne, et al.
Publicado: (2021)

Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
por: Rodriguez, Alfredo E., et al.
Publicado: (2016)

The everlasting dispute between coronary bypass and angioplasty in patients with multivessels coronary artery disease: results of the SYNTAX II study
por: Indolfi, Ciro, et al.
Publicado: (2019)

Multivessel Woven Coronary Artery Disease
por: Dallan, Luis Roberto Palma, et al.
Publicado: (2021)

Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Double stent loss during multivessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome
por: Hawranek, Michał, et al.
Publicado: (2014)

Association between Phenotypic Age and Mortality in Patients with Multivessel Coronary Artery Disease
por: Ma, Qiong, et al.
Publicado: (2022)

Acute coronary syndromes and multivessel coronary artery disease
por: Zimbardo, Giuseppe, et al.
Publicado: (2023)

Eculizumab treatment for paroxysmal nocturnal haemoglobinuria in a patient with recurrent simultaneous multivessel coronary stent thrombosis
por: De Maria, Giovanni Luigi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sc9602nqd6pi8d4lt0q8141jrf